Biotech Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy January 23, 2024
Biotech Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B January 23, 2024
Biotech Gannex’s Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH January 23, 2024
Biotech PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope January 18, 2024
Search
